Market niche Small team focused on a medical obesity device presents a clear opportunity to partner with larger device manufacturers or distributors to scale manufacturing, regulatory support, and global reach.

Strategic partnerships Leverage potential alignment with established players in gastrointestinal devices (e.g., endoscopy and obesity treatment) to co-market or license the adjustable gastric balloon technology.

Validation path Pursue clinical evidence and regulatory milestones that can de-risk sales to clinics and hospital networks, using readiness for FDA interactions as a talking point with buyers.

Digital footprint Utilize existing tech stack and Trustpilot presence to support buyer due diligence; emphasize cloud infrastructure, data security, and customer feedback as differentiators in enterprise discussions.

Growth signals Target mid-sized gastroenterology practices and regional distributors with scalable manufacturing and after-sales service commitments to accelerate adoption and improve patient outcomes.